Previous 10 | Next 10 |
2023-12-05 14:05:27 ET More on Clearmind Medicine Inc., SciSparc Ltd., etc. SciSparc stock slides 12% amid shareholder rights plan, study results Clearmind, SciSparc slide amid weight-loss study results Financial information for Clearmind Medicine Inc. Financ...
2023-12-05 12:36:51 ET More on Mid-day movers stocks. Meiwu technology company limited received nasdaq delisting determination Seeking Alpha’s Quant Rating on NuZee, Inc. Historical earnings data for NuZee, Inc. Financial information for NuZee, Inc. ...
2023-12-05 12:35:14 ET DENVER, Colo., Dec. 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Clearmind Medicine Inc (NASDAQ: CMND), Harbor Custom Development Inc (NASDAQ: HCDI), Volato Group Inc (...
2023-12-05 12:02:50 ET The following mentioned companies are now trading post split- Siyata Mobile (NASDAQ: SYTA), Incannex Healthcare Inc (NASDAQ: IXHL), Yoshiharu Global Co. (NASDAQ: YOSH), Clearmind Medicine Inc (NASDAQ: CMND), Addvantage Technologies Group Inc (NASDAQ: AEY), and Tenon M...
2023-12-05 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Travere Therap...
2023-12-05 09:55:33 ET DENVER, Colo., Dec. 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Allarity Therapeutics Inc (NASDAQ: ALLR), Clearmind Medicine Inc (NASDAQ: CMND), Harbor Custom Development Inc...
Tel Aviv, Israel / Vancouver, Canada, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treat...
2023-12-05 08:28:55 ET Losers: Replimune Group ( REPL ) -50% presents new data from IGNYTE clinical trial of RP1 in Anti-PD1 failed Melanoma and non-Melanoma skin cancers. iBio ( IBIO ) -38% announces pricing of $4.5 Million public offering . Designer B...
2023-12-01 12:52:15 ET Gainers: Neximmune ( NEXI ) +304% . Green Giant ( GGE ) +97% . XBP Europe Holdings ( XBP ) +89% . ShiftPixy ( PIXY ) +47% . Clearmind Medicine ( CMND ) +33% . Elastic N.V ( ESTC ) +34% . Gen...
2023-12-01 08:31:39 ET Neximmune ( NEXI ) +338% . Jeffs Brands ( JFBR ) +64% Received Regulatory Approvals in Spain and The Netherlands to Commence Sales. ShiftPixy ( PIXY ) +26% . Altimmune ( ALT ) +38% pulls back from twice...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that an additional p...